Home Priothera

Priothera

Priothera

Priothera
Category
Business Description
Priothera is a clinical-stage company developing orally applied sphingosine 1 phosphate (S1P) receptor modulators for hematological malignancies. We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic HematopoieticStem Cell Transplantation (HSCT) in these patients.
Based in
Dublin
Tags
clinical-stage, hematological, sphingosine
Total Funding
Above €25 million
Founded
2020
Website
https://priothera.com/

Articles about Priothera:

💡 You're a corporate or investor and looking for startups that are innovating in the same market as Priothera? We're happy to assist you with our Startup Sourcing service.
7/7
You can read only 0 more article for free this week. Become a CLUB Member for unlimited access to EU-Startups.